IL1B and familial Mediterranean fever: In this setting, blocking the activity of IL-1 by biologic agents may reset the autonomous production of IL-1β, and some of these colchicine refractory-FMF patients may experience a stable disease course with regained good response to colchicine (Figures 1ii-b) (44).